Whitehawk Therapeutics (WHWK) Times Interest Earned (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Times Interest Earned of -$2.92 for Q1 2026, up 98.1% year-over-year from -$1.47 in Q1 2025, and down 101.16% quarter-over-quarter from $251.38 in Q4 2025.
Whitehawk Therapeutics (WHWK) Times Interest Earned (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Times Interest Earned for 17 consecutive years, with -$2.92 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 98.1% year-over-year to -$2.92; the TTM figure through Mar 2026 stood at -$15.21 (up 87.31% YoY), while the FY2025 annual figure was -$35.67, down 6346.0% from the prior year.
- Times Interest Earned fell to -$2.92 in Q1 2026 per WHWK's latest filing, from $251.38 in the prior quarter.
- Across five years, Times Interest Earned topped out at $251.38 in Q4 2025 and bottomed at -$271.44 in Q4 2022.
- Historically, Times Interest Earned has averaged -$53.65 across 5 years, with a median of -$46.25 in 2024.
- Annual changes were most pronounced in 2022 — Times Interest Earned tumbled 1157.99% — and 2025, when it soared 691.68%.
- Whitehawk Therapeutics' Times Interest Earned stood at -$271.44 in 2022, then surged by 145.32% to $123.01 in 2023, then slumped by 134.54% to -$42.49 in 2024, then jumped by 691.68% to $251.38 in 2025, then slumped by 101.16% to -$2.92 in 2026.
- Business Quant data shows WHWK's Times Interest Earned at -$2.92 in Q1 2026, $251.38 in Q4 2025, and -$36.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | -1.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.06 |
| Mar 31, 2026 | -2.92 |
| Dec 31, 2025 | 251.38 |
| Sep 30, 2025 | -36.26 |
| Jun 30, 2025 | -119.28 |
| Mar 31, 2025 | -153.72 |
| Dec 31, 2024 | -42.49 |
| Sep 30, 2024 | -46.25 |
| Jun 30, 2024 | -55.66 |
| Mar 31, 2024 | -154.86 |
| Dec 31, 2023 | 123.01 |
| Sep 30, 2023 | -11.30 |
| Jun 30, 2023 | -11.47 |
| Mar 31, 2023 | -135.69 |
| Dec 31, 2022 | -271.44 |
| Sep 30, 2022 | -187.95 |
| Jun 30, 2022 | -6.60 |
| Mar 31, 2022 | -50.60 |
| Dec 31, 2021 | -23.98 |
| Sep 30, 2021 | -319.82 |